Last updated: 27 August 2024 at 9:24pm EST

Adam Grossman Net Worth




The estimated Net Worth of Adam S Grossman is at least $45.2 Million dollars as of 26 August 2024. Mr. Grossman owns over 626,245 units of Adma Biologics Inc stock worth over $41,413,977 and over the last 11 years he sold ADMA stock worth over $2,109,500. In addition, he makes $1,702,020 as President, Chief Executive Officer, Co-Founder, and Director at Adma Biologics Inc.

Mr. Grossman ADMA stock SEC Form 4 insiders trading

Adam has made over 40 trades of the Adma Biologics Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently he exercised 626,245 units of ADMA stock worth $2,905,777 on 26 August 2024.

The largest trade he's ever made was exercising 2,100,459 units of Adma Biologics Inc stock on 15 August 2023 worth over $6,532,427. On average, Adam trades about 65,007 units every 57 days since 2013. As of 26 August 2024 he still owns at least 2,449,082 units of Adma Biologics Inc stock.

You can see the complete history of Mr. Grossman stock trades at the bottom of the page.





Adam Grossman biography

Adam S. Grossman serves as President, Chief Executive Officer, Co-Founder, Director of the Company. Mr. Grossman has been a director of the Company since 2007, has served as the Company’s President and Chief Executive Officer since October 2011 and as the Company’s President and Chief Operating Officer between 2007 and October 2011. Mr. Grossman has over 20 years of experience in the blood and plasma industry. Prior to founding the Company, Mr. Grossman was the Executive Vice President of National Hospital Specialties at GenesisBPS, a position he held between 1994 and 2011. He has experience in launching new products, building and managing national and international sales forces, managing clinical trials and completing numerous business development transactions. Previously, he worked at MedImmune, Inc., where he worked on marketing teams for RSV and CMV immunoglobulins, and at the American Red Cross, where he launched new products with the Biomedical Services division. Mr. Grossman received a B.S. in Business Administration, with a specialization in International Business and Marketing, from American University. Mr. Grossman is the son of Dr. Jerrold B. Grossman, our Vice Chairman and co-founder. Mr. Grossman was chosen to serve on the Board because, as the Company’s Chief Executive Officer, he is able to provide the Board with critical insight into the day-to-day operations of the Company.

What is the salary of Adam Grossman?

As the President, Chief Executive Officer, Co-Founder, and Director of Adma Biologics Inc, the total compensation of Adam Grossman at Adma Biologics Inc is $1,702,020. There are no executives at Adma Biologics Inc getting paid more.



How old is Adam Grossman?

Adam Grossman is 43, he's been the President, Chief Executive Officer, Co-Founder, and Director of Adma Biologics Inc since 2011. There are 12 older and no younger executives at Adma Biologics Inc. The oldest executive at Adma Biologics Inc is Dr. James Mond, 74, who is the Exec. VP, Chief Scientific Officer & Chief Medical Officer.

What's Adam Grossman's mailing address?

Adam's mailing address filed with the SEC is 465 New Jersey 17 S, Ramsey, NJ 07446, United States.

Insiders trading at Adma Biologics Inc

Over the last 11 years, insiders at Adma Biologics Inc have traded over $43,950,328 worth of Adma Biologics Inc stock and bought 17,510,201 units worth $56,736,742 . The most active insiders traders include Advisors Llcperceptive Life..., Ag Biotest Pharmaceuticals ..., and Divestiture Trust Biotest. On average, Adma Biologics Inc executives and independent directors trade stock every 34 days with the average trade being worth of $7,366,858. The most recent stock trade was executed by Lawrence P. Guiheen on 9 September 2024, trading 9,000 units of ADMA stock currently worth $97,200.



What does Adma Biologics Inc do?

adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases. adma's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. the target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. adma’s lead product candidate, ri-002, has completed a phase iii clinical trial in patients with pidd and has met the primary endpoint. a bla for ri-002 was accepted by the fda on september 18, 2015. the company has received u.s. patent 9,107,906. for more information, please visit the company's website at www.admabiologics.com.



What does Adma Biologics Inc's logo look like?

Adma Biologics Inc logo

Complete history of Mr. Grossman stock trades at Adma Biologics Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
26 Aug 2024 Adam S Grossman
President and CEO
Option 626,245 $4.64 $2,905,777
26 Aug 2024
2,449,082
14 Jun 2024 Adam S Grossman
President and CEO
Sale 100,000 $10.72 $1,072,000
14 Jun 2024
2,081,475
18 Aug 2023 Adam S Grossman
President and CEO
Sale 250,000 $4.15 $1,037,500
18 Aug 2023
2,273,085
15 Aug 2023 Adam S Grossman
President and CEO
Option 2,100,459 $3.11 $6,532,427
15 Aug 2023
4,623,544
9 Dec 2022 Adam S Grossman
President and CEO
Buy 29,965 $2.86 $85,700
9 Dec 2022
1,143,426
25 Oct 2021 Adam S Grossman
President and CEO
Buy 350,000 $1.00 $350,000
25 Oct 2021
1,128,444
8 Sep 2020 Adam S Grossman
President and CEO
Buy 4,000 $2.24 $8,960
8 Sep 2020
176,098
10 Aug 2020 Adam S Grossman
President and CEO
Buy 6,000 $3.04 $18,240
10 Aug 2020
172,098
11 Feb 2020 Adam S Grossman
President and CEO
Buy 85,714 $3.50 $299,999
11 Feb 2020
878,444
17 May 2019 Adam S Grossman
President and CEO
Buy 30,000 $4.00 $120,000
17 May 2019
821,301
8 Jun 2018 Adam S Grossman
President and CEO
Buy 73,222 $4.78 $350,001
8 Jun 2018
796,301
9 Nov 2017 Adam S Grossman
President and CEO
Buy 485,000 $2.15 $1,042,750
9 Nov 2017
744,000
13 Jul 2017 Adam S Grossman
President and CEO
Option 42,021 $2.68 $112,616
13 Jul 2017
45,732
3 May 2016 Adam S Grossman
President and CEO
Buy 200,000 $6.50 $1,300,000
3 May 2016
843,668
18 Dec 2015 Adam S Grossman
President and CEO
Buy 6,400 $8.47 $54,208
18 Dec 2015
643,668
18 Dec 2015 Adam S Grossman
President and CEO
Buy 6,400 $8.47 $54,208
18 Dec 2015
643,668
7 Dec 2015 Adam S Grossman
President and CEO
Buy 500 $9.00 $4,500
7 Dec 2015
637,268
7 Dec 2015 Adam S Grossman
President and CEO
Buy 500 $9.00 $4,500
7 Dec 2015
637,268
2 Dec 2015 Adam S Grossman
President and CEO
Buy 2,250 $9.15 $20,588
2 Dec 2015
636,768
2 Dec 2015 Adam S Grossman
President and CEO
Buy 2,250 $9.15 $20,588
2 Dec 2015
636,768
1 Dec 2015 Adam S Grossman
President and CEO
Buy 1,800 $9.17 $16,506
1 Dec 2015
634,518
1 Dec 2015 Adam S Grossman
President and CEO
Buy 1,800 $9.17 $16,506
1 Dec 2015
634,518
25 Nov 2015 Adam S Grossman
President and CEO
Buy 1,800 $9.18 $16,524
25 Nov 2015
632,718
25 Nov 2015 Adam S Grossman
President and CEO
Buy 1,800 $9.18 $16,524
25 Nov 2015
632,718
19 Nov 2015 Adam S Grossman
President and CEO
Buy 3,861 $9.21 $35,560
19 Nov 2015
630,918
19 Nov 2015 Adam S Grossman
President and CEO
Buy 3,861 $9.21 $35,560
19 Nov 2015
630,918
19 Mar 2015 Adam S Grossman
President and CEO
Buy 2,000 $8.50 $17,000
19 Mar 2015
627,057
16 Mar 2015 Adam S Grossman
President and CEO
Buy 14,600 $8.01 $116,946
16 Mar 2015
625,057
11 Sep 2014 Adam S Grossman
President and CEO
Buy 4,300 $9.57 $41,151
11 Sep 2014
610,457
22 Aug 2014 Adam S Grossman
President and CEO
Buy 1,000 $9.50 $9,500
22 Aug 2014
606,157
21 Aug 2014 Adam S Grossman
President and CEO
Buy 600 $9.50 $5,700
21 Aug 2014
605,157
13 Aug 2014 Adam S Grossman
President and CEO
Buy 2,100 $9.77 $20,517
13 Aug 2014
604,557
18 Jun 2014 Adam S Grossman
President and CEO
Buy 1,875 $9.59 $17,981
18 Jun 2014
602,457
3 Jun 2014 Adam S Grossman
President and CEO
Buy 425 $9.50 $4,038
3 Jun 2014
600,582
28 May 2014 Adam S Grossman
President and CEO
Buy 200 $9.00 $1,800
28 May 2014
600,157
23 May 2014 Adam S Grossman
President and CEO
Buy 500 $8.24 $4,120
23 May 2014
599,957
21 May 2014 Adam S Grossman
President and CEO
Buy 4,226 $8.15 $34,442
21 May 2014
599,457
19 May 2014 Adam S Grossman
President and CEO
Buy 874 $8.07 $7,053
19 May 2014
595,231
14 May 2014 Adam S Grossman
President and CEO
Buy 13,400 $7.50 $100,500
14 May 2014
594,357
22 Oct 2013 Adam S Grossman
President and CEO
Buy 23,529 $8.50 $199,997
22 Oct 2013
580,957


Adma Biologics Inc executives and stock owners

Adma Biologics Inc executives and other stock owners filed with the SEC include: